Noida, India (PressExposure) March 08, 2011 -- As per our new research report "US Diabetes Market Analysis", the US market for blood glucose testing products is undergoing a significant transition, driven by the advent of new analytical technologies and developments in diabetes treatment. There are about 75 types of glucose meters currently available in the United States, and each one is different from the rest in one way or the other. The blood glucose meter market in the US is anticipated to grow at a CAGR of around 5% during 2010-2015.
Our study indicates that glucose self-monitoring remains a very viable option for a vast majority of diabetic patients in the country and is increasingly considered as the standard of care. Thus, glucose-monitoring meters have undergone vast change, with recent entries featuring non-revolutionary and small-scale improvements.
Besides, we have done thorough research and prudent analysis of the US Diabetes market and identified some critical factors acting as a catalyst for the industry's current and future growth outlook. The report reveals that the diabetes diagnostic market in the US is moving from traditional finger-prick glucose test to more advanced non-invasive blood glucose testing. Moreover, products with improved specificity & sensitivity and speed-up testing will pave the growth of the market in coming years.
The systematic and thorough research studies the US Diabetes market to give an insight into its various segments, including oral diabetic drugs, insulin market, insulin delivery devices market and glucose monitoring market. The comprehensive analysis of the market identifies insulin as the current highest shareholder, but future will see glucose-monitoring market posting a rapid growth.
The report studies the current development process and its effects on various segments of the industry. It contains exhaustive information about the key market players, government initiatives, and patient profile that will help clients to plan marketing strategies and assess opportunity areas in the US diabetes market. The report also includes a section of future projection and cost implications that give a rough idea about the prospective market trends to facilitate clients comprehend the market's progress in future.
For FREE SAMPLE of this report visit: [http://www.rncos.com/Report/IM299.htm]
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm